Atlas Trials

A Bioequivalence Study of PP3M in Patients With Schizophrenia

Clinical trial NCT07493551 · RECRUITING

Trial details

NCT number
NCT07493551
Sponsor
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Schizophrenia
Start date
2024-10-09
Primary completion
2026-12-31
Enrollment
260

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.